Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- DBI -34.4%, KEY -1.1% (guidance)
Other news:
- REPL -53.2% (shares initial primary analysis results from CERPASS clinical trial in advanced cutaneous squamous cell carcinoma and presents new data from ignyte clinical trial of rp1 in anti-pd1 failed melanoma and non-melanoma skin cancers; study did not meet either of the two primary endpoints of complete response rate)
- ATHE -17.9% (to host ATH434 webcast)
- SPHR -10.8% (announces private offering of $225 million of convertible senior notes)
- NOK -7.6% (comments on AT&T (T) vendor plans)
- IAS -6.8% (prices offering of 11 mln shares by investment funds affiliated with Vista Equity Partners at $14.00 per share)
- SWTX -6.8% (prices offering of 9482758 shares of its common stock at $29.00 per share)
- MNSO -2.8% (responds to unusual price and trading volume movements and increase plan in shareholding by managements)
- EVH -2.6% (announces proposed offering of $350.0 million of convertible senior notes due 2029 to pay down senior term loan)
- ATAT -2.2% (commences offering by entities affiliated with Legend Capital for aggregate of 8 mln ADSs)
- LSTR -2% (names new CEO)
- MMSI -1.5% (proposes $550 mln convertible note offering)
- FENC -1.1% (announces incremental $5 million investment from Petrichor)
- TSLA -0.9% (to face class action lawsuit relating to insurance according to Elektrek)
Analyst comments:
- LTH -2.8% (downgraded to Underweight from Neutral at Piper Sandler)
- ALB -2.4% (downgraded to Underweight from Neutral at Piper Sandler)
- EQH -1.6% (downgraded to Mkt Perform from Outperform at Keefe Bruyette)
- LULU -0.6% (downgraded to Outperform from Strong Buy at Raymond James)